Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    " November 05, 2008":" December 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
22 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
23 Completed Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
Conditions: Binge Drinking;   Alcohol Abuse;   Alcohol Dependence;   HIV Infections
Interventions: Behavioral: HIV support group;   Behavioral: CBT
24 Completed
Has Results
Effects of Short-term Growth Hormone in HIV-infected Patients
Condition: HIV Lipodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone Releasing Hormone
25 Completed Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1
Condition: HIV-1
Intervention: Drug: maraviroc
26 Completed Healthy Teen Girls: HIV Risk Reduction
Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
27 Completed A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
Condition: HIV-1 Infections
Interventions: Drug: dapivirine;   Drug: placebo
28 Completed Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125
Condition: HIV
Interventions: Drug: Etravirine;   Drug: Efavirenz
29 Completed
Has Results
Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
Conditions: HIV;   Cardiovascular Diseases;   Atherosclerosis
Interventions: Drug: Pentoxifylline;   Drug: Placebo
30 Completed Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
Conditions: HIV;   Hepatitis C
Interventions: Behavioral: Motivational interviewing;   Behavioral: Educational intervention
31 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
32 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
33 Completed Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Etravirine and Efavirenz
Condition: Sleep Disorders
Interventions: Drug: etravirine;   Drug: efavirenz
34 Unknown  HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse
Condition: Risk Reduction
Interventions: Behavioral: Information-motivation-behavior skills and cognitive processing therapy;   Behavioral: Pre and Post HIV-Test Counseling
35 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years